β2-Adrenergic receptor ablation modulates hepatic lipid accumulation and glucose tolerance in aging mice
- 1 June 2016
- journal article
- Published by Elsevier in Experimental Gerontology
- Vol. 78, 32-38
Abstract
No abstract availableKeywords
Funding Information
- VA Merit Review Award (1I01BX001744-01 to AK)
- Kronos Longevity Research Institute Award (to MSK)
This publication has 46 references indexed in Scilit:
- Changes in Nucleosome Occupancy Associated with Metabolic Alterations in Aged Mammalian LiverCell Reports, 2014
- Peripheral Adrenoceptors: The Impetus Behind Glucose Dysregulation and Insulin ResistanceJournal of Neuroendocrinology, 2013
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Peroxisome Proliferator-activated Receptor-γ Coactivator-1α (PGC-1α) Stimulates VLDL Assembly through Activation of Cell Death-inducing DFFA-like Effector B (CideB)Journal of Biological Chemistry, 2010
- Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver diseaseJournal of Clinical Investigation, 2005
- Leptin regulation of bone resorption by the sympathetic nervous system and CARTNature, 2005
- Targeted Disruption of the β2 Adrenergic Receptor GeneJournal of Biological Chemistry, 1999
- β-Adrenoreceptor Subtype Expression in Human Liver*The Journal of Clinical Endocrinology & Metabolism, 1990
- Glucose Intolerance and AgingDiabetes Care, 1981
- Epinephrine-induced Insulin Resistance in ManJournal of Clinical Investigation, 1980